Regenerative Medicine
Wharton's Jelly Stem Cells
The strongest stem cell source — sourced from umbilical cord tissue, the most potent and undifferentiated mesenchymal stem cells available.
Wharton's Jelly is the gelatinous tissue inside the umbilical cord — and it contains the highest concentration of mesenchymal stem cells (MSCs) found in any ethically sourced tissue. These cells are younger, more potent, and less differentiated than adult-derived stem cells (bone marrow or adipose). At Elements, our Wharton's Jelly product is sourced from rigorously screened, FDA-compliant tissue banks under strict ethical and clinical protocols.
Wharton's Jelly mesenchymal stem cells (WJ-MSCs) signal regeneration through paracrine mechanisms — they release growth factors, exosomes, and cytokines that direct surrounding tissue to heal. Unlike adult MSCs which decline with donor age, WJ-MSCs come from the youngest available human tissue and retain maximum biological activity. We use them for: chronic joint degeneration, autoimmune-modulated inflammation, soft tissue injury that hasn't responded to conventional treatment, post-surgical recovery acceleration, and select neurological conditions. Treatment is delivered IV for systemic effect or directly into target tissue. Contraindications include active malignancy, certain autoimmune diseases on biologics, pregnancy, and active infection. Wharton's Jelly products are regulated under FDA HCT/P 361 — minimal manipulation only, no claims to treat specific diseases. Honest expectation-setting at consultation.
Key Benefits
Common Questions
Frequently asked
Why are Wharton's Jelly stem cells stronger than bone marrow stem cells?
Wharton's Jelly is umbilical cord tissue from healthy newborns — the youngest available human source of mesenchymal stem cells. These cells have higher proliferation capacity, more potent paracrine signaling, and less differentiation than adult-derived bone marrow or adipose stem cells. The donor age effect is well-documented in the regenerative medicine literature.
Are these ethically sourced?
Yes. Wharton's Jelly is collected from the umbilical cord after live births, with full maternal consent and donor screening. The tissue would otherwise be discarded. No fetal tissue is involved at any stage.
How are they delivered?
Either IV for systemic effect (chronic inflammation, immune modulation, post-viral recovery) or directly into a target tissue under clinical guidance (joint injections, soft tissue, etc.).
How is this different from PRP?
PRP uses your own platelets and growth factors. Wharton's Jelly delivers exogenous mesenchymal stem cells with their entire signaling profile. They're different tools — sometimes combined, often used for different goals.
Are there FDA approvals for stem cell therapy?
Wharton's Jelly products are regulated under FDA HCT/P 361 — minimal manipulation only. We make no claims to treat specific diseases. Our protocols are guided by published research and ongoing physician oversight.
How many sessions are needed?
Most patients respond well to a single session, with re-evaluation at 8–12 weeks. Some chronic conditions benefit from a follow-up at 6 months. Honest assessment at consultation.
Start here
Book now to talk through whether wharton's jelly stem cells is the right fit for your goals, timeline, and recovery plan.
Book now →Related Protocols